Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 91Unknown 25Recruiting 13Terminated 12Active not recruiting 12Withdrawn 4Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neoplasms 1Glioblastoma 1Astrocytoma 1

Interventions

Bevacizumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 2Everolimus 2Biopsy 2trametinib 1relatlimab 1pembrolizumab 1lutetium Lu 177 dotatate 1fluoromisonidazole 1fludarabine phosphate 1antineoplaston AS 2-1 1antineoplaston A10 1aldesleukin 1X-Rays 1Transcranial Magnetic Stimulation 1TPI-287 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Nivolumab 1Niacinamide 1Niacin 1Metformin 1Mental Status and Dementia Tests 1Magnetic Resonance Imaging 1Lomustine 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carboplatin × CNS × Clear all
NCT01386710 2026-06-01

Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma

Northwell Health

Phase 1/2 Suspended
54 enrolled
CNS

Astrocytoma, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡